If newly proposed U.S. Food and Drug Administration regulations were to go into practice, research labs around the U.S. could find it harder to pursue their work editing the genomes of animals.
Gene-editing of animals, one of our 10 Breakthrough Technologies in 2014, is already underway in many labs around the world. Researchers have used the CRISPR-Cas9 technique, for instance, to heal mice of muscular dystrophy, breed extra-muscular beagles, and create hornless cows (they’re safer to farm).
But newly proposed regulations from the FDA may make it harder for research scientists to carry out such work. The new guidance suggests that in the future “each specific genomic alteration [to an animal’s genome would be] considered to be a separate new animal drug subject to new animal drug approval requirements.” The FDA, then, would have to examine every intentionally gene-edited animal for safety in a process similar to the way it deals with drugs now.
As a report by Nature reveals, some researchers object to the proposal on the grounds that it would prove overly burdensome for academics. Instead, they argue that only organizations with greater resources—such as private companies—would be able to push on with their own commercial research, while researchers in other countries with different regulatory frameworks would remain unaffected. One scientist told Nature that the new regulations would be a “disservice to innovation” in the U.S.
The other side of the coin, of course, is that the public often gets fidgety about genetically modified crops, and it’s understandable that similar work in animals would evoke a stronger response. The FDA may be trying to head off controversy by ensuring that it checks in on each and every gene-edited animal created in American labs.
These are, however, only proposed guidelines. As the newly empowered Trump administration swings into action, it may seek to do something else entirely with the proposal—from tossing it in the trash to making it even more strict.
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.